Topic: wearable intensive nerve stimulation
The FDA has approved the first medical device to help reduce abdominal pain in adolescents with IBS through the use of nerve stimulation.
To bring its nerve-stimulating wearable to market, Cala Health collected $50 million that it also plans to use to expand its therapeutic pipeline.
Cala Health launched a collaboration with Massachusetts General Hospital to build out its noninvasive nerve stimulation platform.
The FDA cleared SPR Therapeutics’ single- and dual-lead nerve stimulation devices as non-opioid alternatives for acute and chronic pain relief.